This group of talks is
accredited for up to 2.0 AMA PRA Category 1 credits™.
This group of talks has a single post-test,
which must be completed along with an evaluation
form to obtain credit. The links to the post-test appear on the individual talk pages.

Chronic kidney disease affects 30-40 million Americans, of whom several
thousand require renal replacement therapy. These selected lectures
are chosen by the HDCN editor and ASN Postgraduate Medical Director
to reflect those areas of practice of greatest interest to the
clinician, and areas where recent progress has occurred. The
web extension of these ASN lectures will allow nephrologists
and other physicians who were unable to attend the live sessions
to gain similar benefit from these presentations.

ACCREDITATION STATEMENT:

Accreditation Statement
The American Society of Nephrology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The ASN designates this educational activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The American Medical Association has determined that non-US licensed physicians who participate in this CME activity are eligible for AMA PRA Category 1 Credit™.

SPONSORSHIP / SUPPORT :

This official ASN symposium was supported by a restricted educational grant from Watson Pharmaceuticals, Inc.

FACULTY DISCLOSURE STATEMENTS :

American Society of Nephrology as well as HDCN have conflict of interest
policies that requires course faculty to disclose any real or
apparent commercial financial affiliations related to the content
of their presentations/materials. It is not assumed that these
financial interests or affiliations will have an adverse impact
on faculty presentations; they are simply noted here to fully
inform participants. Speaker disclosures are posted on each individual talk page.

DISCLOSURE OF UNLABELED USE:

This educational activity may contain discussion of
published and/or
investigational uses of agents that are not indicated by FDA. The
American Society
of Nephrology and HDCN do not
recommend the
use of any agent outside of the labeled indications. Please refer
to the official
prescribing information for each product for discussion of approved
indications,
contraindications and warnings. Speaker disclosure about individual talks is posted on each individual talk page.

DISCLAIMER:

Participants have an implied responsibility to use the newly acquired
information to enhance patient outcomes and their own professional
development. The information presented in this activity is not
meant to serve as a guideline for patient management. Any procedures,
medications, or other courses of diagnosis or treatment discussed
or suggested in this activity should not be used by clinicians
without evaluation of their patient's conditions and possible
contraindications on dangers in use, review of any applicable
manufacturer's product information, and comparison with recommendations
of other authorities.

USER INSTRUCTIONS:

To complete this educational activity, the user will need Windows or Macintosh operating
software, a connection to the internet with a 28.8 kbps MODEM or better. The computer should have
an audio card with speakers. An audio player, either the Windows Media Player from Microsoft or
the Real Player from Real Media (www.real.com) is required and either can be downloaded for free
per instructions on the individual lecture pages. Flash version 8.0 is required for the full-screen slide version of the program. Acrobat Reader is required to print the CME
certificate, and this can be download free from www.adobe.com.

For any questions concerning this specific activity please send
an email to
or email@asn-online.org,
or call HDCN at 630-325-3276.